NASDAQ:CMII

CM Life Sciences II Stock Forecast, Price & News

$13.05

+0.18 (+1.40 %)

(As of 06/18/2021 12:00 AM ET)

Add

Compare

Today's Range

$12.90

▼

$14.00

50-Day Range N/A

52-Week Range

$10.23

▼

$14.39

Volume27,297 shs

Average Volume12,405 shs

Market Capitalization$360.18 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

30 days | 90 days | 365 days | Advanced Chart

Receive CMII News and Ratings via Email

Sign-up to receive the latest news and ratings for CM Life Sciences II and its competitors with MarketBeat's FREE daily newsletter.

About CM Life Sciences II

CM Life Sciences II Inc. does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the life sciences sector. The company was incorporated in 2020 and is based in New York, New York.

CM Life Sciences II (NASDAQ:CMII) Stock Price Down 4.6%
June 3, 2021 | americanbankingnews.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry N/A
Sub-IndustryN/A
SectorUnclassified
Current SymbolNASDAQ:CMII
Previous Symbol
CUSIPN/A
CIKN/A
WebN/A
Phone212 474 6745
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares27,600,000
Market Cap$360.18 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

0.00 out of 5 stars

Unclassified Sector

414th out of 541 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for CM Life Sciences II.

0.0 Community Rank

Outperform Votes
CM Life Sciences II has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
CM Life Sciences II has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about CM Life Sciences II and other stocks. Vote “Outperform” if you believe CMII will outperform the S&P 500 over the long term. Vote “Underperform” if you believe CMII will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
CM Life Sciences II does not currently pay a dividend.
Dividend Growth
CM Life Sciences II does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, CM Life Sciences II insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

CM Life Sciences II (NASDAQ:CMII) Frequently Asked Questions

What stocks does MarketBeat like better than CM Life Sciences II?

Wall Street analysts have given CM Life Sciences II a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CM Life Sciences II wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are CM Life Sciences II's key executives?

CM Life Sciences II's management team includes the following people:

Mr. Eli Decatur Casdin, CEO & Director
Mr. Brian Emes, CFO & Sec. (Age 38)
Dr. Shaun Kevin Rodriguez, Chief Strategy Officer (Age 43)

Who are some of CM Life Sciences II's key competitors?

Some companies that are related to CM Life Sciences II include Foley Trasimene Acquisition (WPF), Reinvent Technology Partners Y (RTPY), Ares Acquisition (AAC), Compute Health Acquisition (CPUH), Thoma Bravo Advantage (TBA), Cohn Robbins (CRHC), Apollo Strategic Growth Capital (APSG), Austerlitz Acquisition Co. I (AUS), GS Acquisition Holdings Corp II (GSAH), CONX (CONX), Radius Global Infrastructure (RADI), Ajax I (AJAX), Apollo Strategic Growth Capital II (APGB), Pontem (PNTM) and CC Neuberger Principal Holdings II (PRPB).
View all of CMII's competitors.

What is CM Life Sciences II's stock symbol?

CM Life Sciences II trades on the NASDAQ under the ticker symbol "CMII."

How do I buy shares of CM Life Sciences II?

Shares of CMII can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CM Life Sciences II's stock price today?

One share of CMII stock can currently be purchased for approximately $13.05.

How much money does CM Life Sciences II make?

CM Life Sciences II has a market capitalization of $360.18 million.

How can I contact CM Life Sciences II?

The company can be reached via phone at 212 474 6745.

This page was last updated on 6/18/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.